Skip to main content
. 2022 May 16;28:1610322. doi: 10.3389/pore.2022.1610322

FIGURE 1.

FIGURE 1

Changes in the metabolic activity and proliferation of the studied cell groups under the influence of each treatment combination. K, control, non-treated HT29 cells; g, genomic deoxyribonucleic acid; Kg, gDNA-treated HT29 cells; O, ODN2088 CpG oligonucleotide; P, picropodophyllin; C, chloroquine; SD, standard deviation.